We also unraveled that immunotherapy based on the administration of neutralizing antibody directed against CD8+ T cells promotes cardiac repair in a mouse model of MI as well as in a pig model of cardiac ischemia-reperfusion. Here, CD8A is linked to myocardial infarction.